<ѻý>Four Might Be the Magic Number for Anticoagulation of Subclinical Afibѻý> ARTESiA trial analysis suggests a key threshold for CHA2DS2-VASc score May 20, 2024
<ѻý>Early CRT Benefits HF With Moderately Reduced Ejection Fractionѻý> Trial suggests a possible disease modifying benefit May 20, 2024
<ѻý>Leadless Pacing Wirelessly Linked to Subcutaneous Defibrillator Hits Targets for ATPѻý> Modular leadless system could expand S-ICD use by offering painless anti-tachycardia pacing May 20, 2024
<ѻý>Mediterranean Diet After Afib Ablation: Maybe?ѻý> Randomized trial fails to show benefit except in one group May 19, 2024
<ѻý>Novel Heart Device Lead Sails Through Performance Hurdlesѻý> Next-gen Medtronic ICD lead wire meets pivotal trial safety and efficacy endpoints May 18, 2024
<ѻý>AI-Guidance Boosts Arrhythmia Ablation Success in Persistent Casesѻý> Randomized trial proves advantage of tailored targets May 18, 2024
<ѻý>Removing Conduction System Pacing Leads: Good Success So Farѻý> Study reassures, but long dwell times are largely yet to come May 18, 2024
<ѻý>Prehospital Hypertension Control No Help in Unselected Acute Strokeѻý> Chinese trial suggests benefit for one stroke subtype but may need replication May 16, 2024
<ѻý>Novel Cardiac Myosin Inhibitor Improves Exercise Capacity in HCMѻý> Drug appears on par for efficacy, possibly safer than first drug approved in the class May 13, 2024
<ѻý>Hypertrophic Cardiomyopathy Guidelines Add Drug Class, Endorse More Exerciseѻý> Also, several new recommendations in update address younger patients May 08, 2024